Masimo EBITDA Margin 2010-2024 | MASI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Masimo (MASI) over the last 10 years. The current EBITDA margin for Masimo as of March 31, 2024 is .
Masimo EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $1.98B $0.23B 11.69%
2023-12-31 $2.05B $0.24B 11.57%
2023-09-30 $2.12B $0.32B 15.26%
2023-06-30 $2.19B $0.31B 13.95%
2023-03-31 $2.30B $0.34B 14.94%
2022-12-31 $2.04B $0.35B 17.05%
2022-09-30 $1.75B $0.28B 16.09%
2022-06-30 $1.50B $0.33B 21.68%
2022-03-31 $1.24B $0.31B 24.68%
2021-12-31 $1.24B $0.31B 25.18%
2021-09-30 $1.21B $0.30B 24.71%
2021-06-30 $1.18B $0.29B 24.47%
2021-03-31 $1.17B $0.28B 24.13%
2020-12-31 $1.14B $0.28B 24.83%
2020-09-30 $1.10B $0.28B 25.34%
2020-06-30 $1.05B $0.27B 25.67%
2020-03-31 $0.98B $0.26B 26.41%
2019-12-31 $0.94B $0.24B 25.99%
2019-09-30 $0.91B $0.24B 25.82%
2019-06-30 $0.90B $0.23B 25.89%
2019-03-31 $0.88B $0.23B 26.31%
2018-12-31 $0.86B $0.23B 26.66%
2018-09-30 $0.84B $0.22B 26.07%
2018-06-30 $0.83B $0.21B 25.91%
2018-03-31 $0.81B $0.21B 25.56%
2017-12-31 $0.79B $0.20B 25.82%
2017-09-30 $0.78B $0.48B 61.81%
2017-06-30 $0.76B $0.48B 62.93%
2017-03-31 $0.74B $0.47B 63.46%
2016-12-31 $0.71B $0.45B 63.53%
2016-09-30 $0.68B $0.16B 24.15%
2016-06-30 $0.66B $0.16B 23.34%
2016-03-31 $0.65B $0.15B 22.57%
2015-12-31 $0.63B $0.14B 21.55%
2015-09-30 $0.63B $0.13B 20.93%
2015-06-30 $0.62B $0.13B 20.26%
2015-03-31 $0.60B $0.11B 18.94%
2014-12-31 $0.59B $0.12B 19.76%
2014-09-30 $0.57B $0.10B 16.93%
2014-06-30 $0.55B $0.09B 16.97%
2014-03-31 $0.55B $0.10B 18.00%
2013-12-31 $0.55B $0.09B 16.85%
2013-09-30 $0.54B $0.10B 18.84%
2013-06-30 $0.52B $0.10B 18.51%
2013-03-31 $0.51B $0.10B 18.82%
2012-12-31 $0.49B $0.09B 19.07%
2012-09-30 $0.47B $0.09B 19.24%
2012-06-30 $0.46B $0.09B 20.09%
2012-03-31 $0.45B $0.09B 20.45%
2011-12-31 $0.44B $0.09B 21.41%
2011-09-30 $0.43B $0.10B 21.94%
2011-06-30 $0.43B $0.10B 22.79%
2011-03-31 $0.42B $0.10B 23.10%
2010-12-31 $0.41B $0.11B 27.59%
2010-09-30 $0.39B $0.11B 28.50%
2010-06-30 $0.38B $0.11B 29.02%
2010-03-31 $0.36B $0.11B 30.03%
2009-12-31 $0.35B $0.09B 25.50%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $6.723B $2.048B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.743B 27.48
Intuitive Surgical (ISRG) United States $141.891B 85.48
Edwards Lifesciences (EW) United States $54.101B 35.21
DexCom (DXCM) United States $51.973B 78.73
IDEXX Laboratories (IDXX) United States $43.777B 51.31
Alcon (ALC) Switzerland $43.442B 31.13
IQVIA Holdings (IQV) United States $41.922B 24.32
STERIS (STE) Ireland $22.999B 26.88
Waters (WAT) United States $21.000B 30.86
SONOVA HOLDING (SONVY) Switzerland $18.908B 0.00
Hologic (HOLX) United States $17.468B 19.54
Fresenius Medical Care AG KGaA (FMS) Germany $12.869B 15.02
ShockWave Medical (SWAV) United States $12.384B 77.07
Sysmex ADR (SSMXY) Japan $11.134B 34.91
Teleflex (TFX) United States $10.108B 15.73
Globus Medical (GMED) United States $8.970B 26.29
Penumbra (PEN) United States $7.809B 88.74
Glaukos (GKOS) United States $5.504B 0.00
TransMedics (TMDX) United States $4.566B 433.19
Integer Holdings (ITGR) United States $4.029B 24.34
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.318B 19.70
Tandem Diabetes Care (TNDM) United States $3.051B 0.00
Elekta AB (EKTAY) Sweden $2.973B 20.40
Inari Medical (NARI) United States $2.682B 0.00
Nihon Kohden (NHNKY) Japan $2.474B 20.92
RxSight (RXST) United States $2.317B 0.00
Integra LifeSciences Holdings (IART) United States $2.126B 9.27
Veracyte (VCYT) United States $1.705B 0.00
Alphatec Holdings (ATEC) United States $1.543B 0.00
Artivion (AORT) United States $0.993B 95.24
AVANOS MEDICAL, INC (AVNS) United States $0.933B 18.14
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.897B 0.00
OrthoPediatrics (KIDS) United States $0.775B 0.00
Mesa Laboratories (MLAB) United States $0.656B 22.26
Paragon 28 (FNA) United States $0.621B 0.00
SiBone (SIBN) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.555B 31.07
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Pulse Biosciences (PLSE) United States $0.474B 0.00
Nevro (NVRO) United States $0.386B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.10
Treace Medical Concepts (TMCI) United States $0.306B 0.00
Sight Sciences (SGHT) United States $0.282B 0.00
AxoGen (AXGN) United States $0.271B 0.00
908 Devices (MASS) United States $0.236B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
EDAP TMS S.A (EDAP) France $0.231B 0.00
NeuroPace (NPCE) United States $0.230B 0.00
Delcath Systems (DCTH) United States $0.223B 0.00
Inogen (INGN) United States $0.207B 0.00
Atossa Genetics (ATOS) United States $0.201B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.168B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
Accuray (ARAY) United States $0.159B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.59
KORU Medical Systems (KRMD) United States $0.101B 0.00
Yubo Biotech (YBGJ) China $0.091B 0.00
Neuronetics (STIM) United States $0.076B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Envoy Medical (COCH) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.056B 0.00
SEP Acquisition (SEPA) United States $0.054B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.046B 0.00
Autonomix Medical (AMIX) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Aspira Women's Health (AWH) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00